Brief: Oncopeptides To Present Additional Data From Ocean Study
Nov 13 (Reuters) - Oncopeptides AB ONCO.ST :
* ONCOPEPTIDES SELECTED TO PRESENT ADDITIONAL DATA FROM OCEAN STUDY AT THE AMERICAN SOCIETY
OF
HEMATOLOGY MEETING
* LONG-TERM FOLLOW-UP OF OCEAN CONFIRMS FAVORABLE SAFETY AND OVERALL SURVIVAL OUTCOMES OF
MELFLUFEN + DEXAMETASON
Source text for Eikon: ID:nMFN5nQ3Xf
Further company coverage: ONCO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Oncopeptides AB
See all newsSweden's Oncopeptides Q3 net sales rise on Pepaxti demand
Brief: Oncopeptides Q3 Operating Profit SEK -36.47 Million
Brief: Oncopeptides Completes Directed Share Issue Of SEK 100 Mln
Brief: Oncopeptides Confirms Blood-Brain-Barrier Penetration In Glioblastoma Study
Swedish biotech Oncopeptides' Q2 net sales rise on strong demand in Italy